Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Central sensitization, the hyperexcitability of spinal processing that often accompanies peripheral injury, is a major component of many persistent pain states. Here we report that the neurotrophin, brain-derived neurotrophic factor (BDNF), is a modulator of excitability within the spinal cord and contributes to the mechanism of central sensitization. BDNF, localized in primary sensory neuron cell bodies and central terminals, potentiates nociceptive spinal reflex responses in an in vitro spinal cord preparation and induces c-fos expression in dorsal horn neurons. NMDA receptor-mediated responses, known as a major contributor to central sensitization, were significantly enhanced by exogenous BDNF. Systemic NGF treatment, a procedure that mimics peripheral inflammatory states, raises BDNF levels in sensory neurons and increases nociceptive spinal reflex excitability. This increased central excitability is reduced by trkB-IgG, a BDNF "antagonist." We also show directly that inflammatory pain-related behavior depends on BDNF release in vivo. Thus behavioral nociceptive responses induced by intraplantar formalin and by intraplantar carageenan are significantly attenuated by trkB-IgG. Hence BDNF is appropriately localized and regulated in inflammatory states and is sufficient and necessary for the expression of central sensitization in the spinal cord. We propose that BDNF may function as a modulator of central sensitization in pathological states, and our results suggest that pharmacological antagonism of BDNF may prove an effective and novel analgesic strategy for the treatment of persistent inflammatory pain states.

Type

Journal article

Journal

J Neurosci

Publication Date

15/06/1999

Volume

19

Pages

5138 - 5148

Keywords

Animals, Animals, Newborn, Behavior, Animal, Brain-Derived Neurotrophic Factor, Carrageenan, Excipients, Excitatory Amino Acid Agonists, Hyperalgesia, Immunoglobulin G, Injections, Spinal, Male, Membrane Potentials, N-Methylaspartate, Nerve Fibers, Neurons, Afferent, Nociceptors, Proto-Oncogene Proteins c-fos, Rats, Rats, Wistar, Receptor Protein-Tyrosine Kinases, Receptor, Ciliary Neurotrophic Factor, Receptors, Nerve Growth Factor, Reflex, Spinal Cord